What is the SNAP-IV?
The SNAP-IV (Swanson, Nolan, and Pelham, Version IV) is a 26-item rating scale used to screen for Attention Deficit Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) in children aged 6 to 18. It was developed by Dr. James Swanson at the University of California, Irvine, and is based directly on the DSM-IV criteria for ADHD and ODD.
The questionnaire is typically completed by parents and/or teachers who observe the child in different settings. It takes approximately 10 minutes to complete and provides subscale scores for inattention, hyperactivity/impulsivity, and oppositional defiance. The SNAP-IV is widely used in both clinical practice and research as a primary outcome measure in ADHD treatment studies, including the landmark MTA (Multimodal Treatment of ADHD) study.
Unlike diagnostic tools, the SNAP-IV is a screening instrument. It helps identify children who may benefit from further evaluation but is not sufficient for diagnosis on its own. A comprehensive ADHD evaluation should include clinical interviews, behavioral observations, rating scales from multiple informants, and consideration of alternative explanations.
Scoring & Interpretation
Each of the 26 items is rated on a 4-point scale:
| Rating | Label | Description |
|---|---|---|
| 0 | Not at All | Behavior is not observed |
| 1 | Just a Little | Behavior is occasionally observed |
| 2 | Quite a Bit | Behavior is frequently observed |
| 3 | Very Much | Behavior is pervasive and impairing |
Scoring uses the average rating per subscale method. The sum of item ratings for each subscale is divided by the number of items in that subscale:
Clinical Significance Cutoffs
| Subscale | Items | Cutoff Average | Interpretation |
|---|---|---|---|
| Inattention | Items 1–9 | ≥ 1.44 | Clinically significant inattention |
| Hyperactivity/Impulsivity | Items 10–18 | ≥ 1.67 | Clinically significant hyperactivity |
| Combined ADHD | Items 1–18 | ≥ 1.67 | Clinically significant combined type |
| Oppositional Defiant | Items 19–26 | ≥ 2.00 | Clinically significant opposition |
These cutoff values are derived from normative data and represent approximately the 95th percentile of teacher ratings. Scores above the cutoff suggest the child exhibits symptoms at a level that warrants further clinical evaluation.
Understanding the Subscales
Inattention (9 Items)
The inattention subscale assesses the core symptoms of inattentive ADHD, including difficulty sustaining attention, poor organizational skills, forgetfulness, and susceptibility to distraction. Children scoring high on this subscale may struggle academically not because of intellectual deficits but because of difficulty maintaining focus on tasks, following multi-step instructions, and keeping track of materials.
Hyperactivity/Impulsivity (9 Items)
This subscale captures the behavioral manifestations of hyperactivity (excessive motor activity, restlessness, inability to sit still) and impulsivity (acting without thinking, blurting out answers, difficulty waiting). These symptoms are often more noticeable in structured settings like classrooms and are typically the reason children are first referred for evaluation.
Oppositional Defiant (8 Items)
The ODD subscale screens for patterns of angry, irritable mood; argumentative, defiant behavior; and vindictiveness. This is particularly relevant because ODD commonly co-occurs with ADHD — approximately 40–60% of children with ADHD also meet criteria for ODD. Identifying comorbid ODD is important for treatment planning, as it may require additional behavioral interventions.
ADHD in Children
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood, affecting approximately 5–7% of children worldwide. It is characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development.
The DSM-5 recognizes three presentations of ADHD:
- Predominantly Inattentive Presentation: Primarily difficulty with attention and organization, without significant hyperactivity. Previously called ADD.
- Predominantly Hyperactive-Impulsive Presentation: Primarily restlessness and impulsive behavior, with relatively intact attention.
- Combined Presentation: Significant symptoms of both inattention and hyperactivity-impulsivity. This is the most common presentation.
ADHD has a strong genetic component, with heritability estimates of approximately 74%. Neuroimaging studies have identified differences in brain structure and function, particularly in the prefrontal cortex and its connections, which underlie the executive function deficits seen in ADHD.
Early identification and intervention can significantly improve outcomes. Treatment typically involves a multimodal approach combining behavioral strategies, educational accommodations, parent training, and, when appropriate, pharmacological treatment with stimulant or non-stimulant medications.
Validation & Research
The SNAP-IV has been extensively validated in research settings. It was the primary outcome measure in the landmark NIMH Multimodal Treatment Study of Children with ADHD (MTA study), which involved 579 children across six clinical sites and remains one of the largest and most influential ADHD treatment studies ever conducted.
Key validation findings include:
- Internal consistency: Cronbach's alpha coefficients range from 0.88 to 0.95 for the different subscales, indicating excellent reliability.
- Test-retest reliability: Correlation coefficients of 0.70–0.90 over 2–4 week intervals.
- Convergent validity: Moderate to strong correlations with other validated ADHD measures including the Conners Rating Scale and the CBCL Attention Problems scale.
- Discriminant validity: Effectively distinguishes between children with and without ADHD diagnoses.
- Sensitivity to treatment effects: Demonstrated ability to detect changes in symptom severity with medication and behavioral interventions.
Clinical Use Guidelines
For optimal use of the SNAP-IV in clinical practice:
- Collect ratings from both parents and teachers to assess symptoms across settings
- Use the rating scale as part of a comprehensive evaluation, not as a standalone diagnostic tool
- Consider that cutoff scores may vary by the informant (parent vs. teacher norms differ)
- Repeat assessments over time to monitor treatment response
- Consider cultural and developmental context when interpreting scores
- Document that symptoms must be present for at least 6 months and cause impairment in 2+ settings for a DSM-5 diagnosis
Frequently Asked Questions
Who should complete the SNAP-IV?
The SNAP-IV is designed to be completed by parents or teachers who regularly observe the child. Ideally, ratings should be obtained from both parents and teachers to assess whether symptoms are present across multiple settings, which is a diagnostic requirement for ADHD.
At what age can the SNAP-IV be used?
The SNAP-IV is validated for children aged 6 to 18. For younger children (preschool age), other instruments such as the ADHD Rating Scale-IV Preschool Version or the Conners Early Childhood may be more appropriate.
What do the cutoff scores mean?
Cutoff scores represent the threshold above which symptom ratings are considered clinically significant, typically at or above the 95th percentile of normative data. Exceeding a cutoff does not mean a child has ADHD — it means further evaluation is warranted. Many conditions can mimic ADHD symptoms, including anxiety, depression, learning disabilities, sleep disorders, and trauma.
How is the SNAP-IV different from the Conners Rating Scale?
Both are widely used ADHD screening tools, but they differ in scope. The SNAP-IV is a brief, freely available tool focused specifically on DSM-IV ADHD and ODD criteria (26 items). The Conners Rating Scale is a more comprehensive commercial instrument with additional scales (e.g., anxiety, learning problems) and age- and gender-normed T-scores. The SNAP-IV is often preferred in research settings for its brevity and direct mapping to diagnostic criteria.
Is the SNAP-IV free to use?
Yes. The SNAP-IV is a public domain instrument and can be used freely for clinical and research purposes without permission or licensing fees. This makes it an accessible tool for clinicians in various practice settings.